Drug Giant AstraZeneca Launches Evinova to Quicken Clinical Trials
Evinova aims to use AI to design studies, automate cost calculations, and determine feasibility for drug testing.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
Coinbase Launches US500 Perps, Bringing 500 U.S. Stocks Into One Crypto Contract
Key Takeaways: Coinbase has introduced US500 Perps, which enables traders to gain exposure to 500 top U.S. companies. It can be tr...
EIP-8130 aims to unify account standards for Ethereum’s EVM
EIP-8130 could streamline Ethereum's ecosystem, enhancing interoperability and efficiency across EVM-compatible chains, fostering...
Ankr launches institutional-grade RPC infrastructure for XRP Ledger
Ankr's infrastructure enhances XRPL's accessibility, reducing barriers for developers and potentially accelerating institutional b...
Aster Launches Five USD1 RWA Perpetual Markets
Key Takeaways: Aster introduced five new USD1 marked RWA perpetuals on equities and commodities. The new markets are supported by...
Aster launches first USD1-denominated RWA perpetual markets with $28M liquidity fund
Aster's USD1-denominated markets could redefine stablecoin utility, enhancing liquidity and integration in real-world asset tradin...
Bitcoin Reclaims $70,000 as Treasury Yields Sink and White House Engagement Fuels Risk Appetite
Bitcoin jumped 4.1% above $71,900 as Treasury yields fell, the dollar hit a three-month low, and Trump's White House crypto meetin...